EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Sialorrhea possibly associated with bupropion: a case report and review of potential mechanisms

Huijie Du, Mei Bai, Lu Yang, Shuqin Jia, Yang Yang, Wei Wang, Xiaowei Luo, Jinxuan Wei

Frontiers in Psychiatry · 01.10.2026 · 17

DOI: 10.3389/fpsyt.2026.1979464 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 01.10.2026. Verfasst von Huijie Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The First People's Hospital of Guiyang, Guiyang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bupropion is typically associated with xerostomia (dry mouth) rather than increased salivation. However, its prescribing information lists “increased salivation” as an infrequent adverse reaction. Case presentation We report the case of a 59-year-old female patient with the diagnosis of comorbid anxiety and depressive disorders. The patient experienced no sialorrhea while on a combination of venlafaxine and low-dose quetiapine. However, after switching venlafaxine to bupropion, she developed significant sialorrhea. The sialorrhea was severe: she had to carry tissues and a plastic bag during the day, and at night the pillow was frequently soaked. Gradual discontinuation of quetiapine did not resolve the symptom. The sialorrhea completely remitted only after bupropion was discontinued and replaced with escitalopram. The Naranjo Adverse Drug Reaction Probability Scale score was 6, indicating a “probable” relationship.

Conclusion

This case suggests that bupropion may induce sialorrhea, potentially through a synergistic mechanism involving noradrenergic pathways when combined with quetiapine. Clinicians should be aware of this rare adverse effect when prescribing bupropion, particularly in combination therapies. Therapeutic drug monitoring and clinical pharmacist collaboration may help prevent such adverse events.

Schlagwörter

Stichwörter der Autor:innen

adverse drug reactionbupropionnorepinephrinequetiapinesialorrhea

Autor:innen und Institutionen

  • Department of Psychiatry, The First People's Hospital of Guiyang, Guiyang, China.
  • Department of Clinical Medicine, Guizhou Medical University, Guiyang, China.

Zitieren

APA

Du, H., Bai, M., Yang, L., Jia, S., Yang, Y., Wang, W., Luo, X., & Wei, J. (2026). Sialorrhea possibly associated with bupropion: a case report and review of potential mechanisms. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1979464

Vancouver

Du H, Bai M, Yang L, Jia S, Yang Y, Wang W, et al. Sialorrhea possibly associated with bupropion: a case report and review of potential mechanisms. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1979464

BibTeX
@article{Du2026,
  author = {Du, Huijie and Bai, Mei and Yang, Lu and Jia, Shuqin and Yang, Yang and Wang, Wei and Luo, Xiaowei and Wei, Jinxuan},
  title = {Sialorrhea possibly associated with bupropion: a case report and review of potential mechanisms},
  journal = {Frontiers in Psychiatry},
  year = {2026},
  volume = {17},
  doi = {10.3389/fpsyt.2026.1979464}
}
Kostenlos starten →